TC Biopharm (Holdings) Plc Sponsored ADR (TCBP) has released an update.
TC Biopharm (Holdings) PLC has informed shareholders about their plan to seek approval for a significant issuance of shares, potentially amounting to 20% or more of the company’s current outstanding shares, at a price potentially below recent closing values. This move, requiring a special shareholder meeting as per Nasdaq rules, is aimed at raising capital through private offerings. However, the company cautions that this contains forward-looking statements, and actual outcomes could differ due to various risks and uncertainties. Shareholders are urged to review the proxy statement and other relevant documents for a comprehensive understanding of the proposal and its associated risks.
For further insights into TCBP stock, check out TipRanks’ Stock Analysis page.
